Furthermore, intact CXCR4 signaling presumably in B-ALL cells is required for downregulation of CXCL12 expression in BM niche cells (van den Berk et al., 2014). The gene discussed is CXCR4; the disease is precursor B-cell acute lymphoblastic leukemia.